Riluzole in the Treatment of Spasticity in the Traumatic Chronic Spinal Cord Injury Condition: Adaptive, Multicenter, Placebo-controlled, Randomised, Double Blind Trial in a Rare Disorder is a PHASE2 clinical asset sponsored by Assistance Publique Hopitaux De Marseille in Spinal Cord Injury. SEO and diligence focus: Riluzole, Placebo, Blood Samples, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.